Emergen logo.png
Dry Eye Syndrome Market Size Worth USD 10.55 Billion in 2032 | Emergen Research
January 10, 2024 07:38 ET | Emergen Research
Vancouver, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global dry eye syndrome market size was USD 5.32 billion in 2022 and is expected to register a revenue CAGR of 7.3% during the forecast period....
Research Nester Logo.jpg
Dry Eye Syndrome Market revenue to cross USD 600 Million by 2035, says Research Nester
July 10, 2023 06:50 ET | Research Nester
New York, July 10, 2023 (GLOBE NEWSWIRE) -- The global dry eye syndrome market is estimated to grow at a CAGR of ~8% from 2023 to 2035. The market is estimated to garner a revenue of ~USD 600...
Future Market Insights.png
Worldwide Demand for Dry Eye Syndrome Treatment Market Will Surge at 7.0% CAGR from 2022 to 2032 | Future Market Insights, Inc. DUBAI, United Arab Emirates, March 02, 2023 (GLOBE NEWSWIRE) -- The global dry eye syndrome treatment market is anticipated to exceed a value of US$ 8.84 billion by 2032, with sales growing at a...
Straits Research Pvt Ltd
OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research
August 18, 2022 10:30 ET | Straits Research
New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...
IMED Dryeye Rescue PR post 798x530 31 Jan 2022 final
I-Med Pharma USA Partners With DryEye Rescue to Distribute Its Innovative Dry Eye Product Portfolio in the United States
February 03, 2022 11:00 ET | I-MED Pharma
MONTREAL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States, I-MED Pharma USA has partnered with...
IMED+NTC website 790x590 30 Nov 2021
NTC and I-MED Pharma form strategic partnership to bring the leading HA-based dry eye ointment to the United States market
December 15, 2021 07:00 ET | I-MED Pharma
MONTREAL, Dec. 15, 2021 (GLOBE NEWSWIRE) -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and...
Michelle Schnabel picture
I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
November 09, 2021 11:00 ET | I-MED Pharma
MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...
FBI LOGO TM.png
Dry Eye Syndrome Market to Reach USD 6.54 Billion by 2027 | Market Size, Share, Growth, Revenue, Competitive Landscape, Forecasts, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™
November 09, 2021 05:12 ET | Fortune Business Insights
Pune, India, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The global dry eye syndrome market size is expected to reach USD 6.54 billion by 2027, exhibiting a CAGR of 4.7% during the forecast period. The...
image0
I-MED Pharma USA Announces Brent Jones as Chief Commercial Officer
November 08, 2021 11:00 ET | I-MED Pharma
MONTREAL, Nov. 08, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer...
I-MEDPharma_Logo_2017 pressrelease (002).jpg
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.
November 05, 2021 11:00 ET | I-MED Pharma
MONTREAL, Nov. 05, 2021 (GLOBE NEWSWIRE) -- I-MED Pharma USA is bringing the world’s most innovative dry eye product portfolio to the U.S. market. Their uniquely formulated line of ocular surface...